| Drug Name |
Neostigmine methylsulfate |
| Drug ID |
BADD_D01554 |
| Description |
A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike physostigmine, does not cross the blood-brain barrier. |
| Indications and Usage |
Neostigmine is used for the symptomatic treatment of myasthenia gravis by improving muscle tone. |
| Marketing Status |
Prescription |
| ATC Code |
N07AA01; S01EB06 |
| DrugBank ID |
DB01400
|
| KEGG ID |
D00998
|
| MeSH ID |
D009388
|
| PubChem ID |
5824
|
| TTD Drug ID |
D08USJ
|
| NDC Product Code |
51662-1557; 51754-1220; 71872-7016; 10695-033; 70121-1479; 0641-6149; 0641-6150; 51927-0191; 70700-171; 68083-384; 70594-072; 63323-413; 59651-243; 42023-188; 0404-9925; 42023-189; 31722-995; 72572-460; 45941-3053; 50090-4532; 14445-015; 0548-9602; 14445-414; 72572-461; 52584-057; 70069-805; 65145-111; 71872-7143; 51754-1240; 70594-069; 66064-1020; 71288-500; 70121-1478; 47621-305; 65145-112; 71839-105; 72572-462; 68083-383; 50090-5197; 76014-003; 25021-610; 76014-903; 71288-501; 70516-0161; 14445-413; 63323-415; 71839-106; 76014-002; 51754-1210; 38779-1851; 70069-806; 76045-383; 31722-994; 0548-9601; 14501-0022; 70700-172; 25021-611 |
| Synonyms |
Neostigmine | Synstigmin | Proserine | Prozerin | Polstigmine | Neostigmine Bromide | Bromide, Neostigmine | Syntostigmine | Neostigmine Methylsulfate | Methylsulfate, Neostigmine | Prostigmine | Prostigmin |
